Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Actinospectacin
2. Adspec
3. Ferkel Spectam
4. Kempi
5. Prospec
6. Salmosan T
7. Salmosan-t
8. Spectam
9. Spectam, Ferkel
10. Spectinomycin
11. Spectinomycin Dihydrochloride, Anhydrous
12. Spectinomycin Dihydrochloride, Pentahydrate
13. Spectinomycin Hydrochloride
14. Stanilo
15. Trobicin
1. 23312-56-3
2. Spectinomycin Sulphate
3. Actinospectacin
4. Trobicin
5. Bz0h4tlf9x
6. Nsc100859
7. Xk 43-1
8. Sulfuric Acid;(1r,3s,5r,8r,10r,11s,12s,13r,14s)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one
9. U 18409
10. Unii-bz0h4tlf9x
11. Togamycin Sulfate (1:1)
12. Einecs 245-578-7
13. Mfcd00270185
14. Actinospectacin Sulfate
15. Schembl134977
16. Actinospectacin Sulphate
17. Chembl1969020
18. Dtxsid40945986
19. Yaa31256
20. Nsc-100859
21. Q-201733
22. Q27274974
23. (2r-(2.alpha.,4a.beta.,5a.beta.,6.beta.,7.beta.,8.beta.,9.alpha.,9a.alpha.,10a.beta.))-decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-4h-pyrano(2,3-b)(1,4)benzodioxin-4-one Sulfate
24. (2r-(2.alpha.,4a.beta.,5a.beta.,6.beta.,7.beta.,8.beta.,9.alpha.,9a.alpha.,10a.beta.))-decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-4h-pyrano(2,3-b)(1,4)benzodioxin-4-one Sulphate
25. 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2r,4ar,5ar,6s,7s,8r,9s,9ar,10as)-, Sulfate (1:1)
26. 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2r,4ar,5ar,6s,7s,8r,9s,9ar,10as)-, Sulphate (1:1)
27. 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, Sulfate (1:1) (salt)
28. 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, Sulphate (1:1) (salt)
29. 4h-pyrano[2,4]benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, [2r-(2.alpha.,4a.beta.,5a.beta.,6.beta.,7.beta.,8.beta.,9.alpha.,9a.alpha.,10a.beta.)]-, Sulfate (1:1) (salt)
30. Sulfuric Acid--4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)decahydro-4h-pyrano[2,3-b][1,4]benzodioxin-4-one (1/1)
| Molecular Weight | 430.43 g/mol |
|---|---|
| Molecular Formula | C14H26N2O11S |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 2 |
| Exact Mass | 430.12573082 g/mol |
| Monoisotopic Mass | 430.12573082 g/mol |
| Topological Polar Surface Area | 213 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 559 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
ABOUT THIS PAGE
A Spectinomycin Sulphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spectinomycin Sulphate, including repackagers and relabelers. The FDA regulates Spectinomycin Sulphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spectinomycin Sulphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Spectinomycin Sulphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Spectinomycin Sulphate supplier is an individual or a company that provides Spectinomycin Sulphate active pharmaceutical ingredient (API) or Spectinomycin Sulphate finished formulations upon request. The Spectinomycin Sulphate suppliers may include Spectinomycin Sulphate API manufacturers, exporters, distributors and traders.
click here to find a list of Spectinomycin Sulphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Spectinomycin Sulphate CEP of the European Pharmacopoeia monograph is often referred to as a Spectinomycin Sulphate Certificate of Suitability (COS). The purpose of a Spectinomycin Sulphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Spectinomycin Sulphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Spectinomycin Sulphate to their clients by showing that a Spectinomycin Sulphate CEP has been issued for it. The manufacturer submits a Spectinomycin Sulphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Spectinomycin Sulphate CEP holder for the record. Additionally, the data presented in the Spectinomycin Sulphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Spectinomycin Sulphate DMF.
A Spectinomycin Sulphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Spectinomycin Sulphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Spectinomycin Sulphate suppliers with CEP (COS) on PharmaCompass.
Spectinomycin Sulphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Spectinomycin Sulphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Spectinomycin Sulphate GMP manufacturer or Spectinomycin Sulphate GMP API supplier for your needs.
A Spectinomycin Sulphate CoA (Certificate of Analysis) is a formal document that attests to Spectinomycin Sulphate's compliance with Spectinomycin Sulphate specifications and serves as a tool for batch-level quality control.
Spectinomycin Sulphate CoA mostly includes findings from lab analyses of a specific batch. For each Spectinomycin Sulphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Spectinomycin Sulphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Spectinomycin Sulphate EP), Spectinomycin Sulphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Spectinomycin Sulphate USP).
LOOKING FOR A SUPPLIER?
